Panbio登革熱診斷試劑盒（膠體金法）

廣州健侖生物科技有限公司

本公司為大家供應各種進口品牌登革熱檢測試劑盒，包括澳洲Panbio、美國NovaBios、美國CORTEZ等美國CDC品牌。主要包括膠體金、酶免、PCR等方法學。歡迎咨詢

Panbio登革熱診斷試劑盒（膠體金法）

非洲工作用登革熱試紙

熱帶國家旅游用登革熱檢測試紙

登革熱IgM抗體、登革熱IgG抗體、登革熱NS1抗原、登革熱早期檢測試劑盒

登革熱核酸檢測試劑盒

Panbio公司簡介:
1、1988年成立，2001年在澳大利亞證券交易所上市。
2、Panbio系關于蟲媒感染性疾病及熱帶感染性疾病的專業供貨商。
3、產品面向蟲媒感染性疾病的檢測，在國內疾控系統具有*的認知和認可度。
4、2010年銷售800萬檢測試劑，為30多種疾病提供診斷。

Panbio登革熱介紹：

1、登革熱快速檢測試劑(Dengue Duo Cassette R-DEN03D)
用于定性的快速檢測人群血清、血漿或全血中登革病毒的IgM及IgG抗體。可在15分鐘內檢測結果。

2、登革IgM捕捉ELISA(Dengue IgM Capture ELISA E-DEN01M)
用于定性的檢測人群血清中登革病毒的IgM抗體，用于臨床實驗室對具有持續發燒的登革熱癥狀的病人的輔助診斷。

3、登革IgG捕捉ELISA(Dengo IgG Capture ELISA E-DEN02G)
用于定性檢測血清中登革病毒(血清型1、2、3及4型)的IgG抗體。用于臨床實驗室對繼發登革熱感染的輔助診斷。

4、登革早期ELISA(Dengue Early ELISA E-DEN01P)
用于定性檢測血清中登革病毒的NS1抗原(血清型1、2、3及4型)。用于臨床實驗室對有持續發燒的登革熱癥狀病人的輔助性診斷。

5、登革IgG間接ELISA(Dengue IgG Indirect ELISA E-DEN01G)
用于定性檢測血清中登革病毒(血清型1、2、3及4型)的IgG抗體，用于臨床實驗室對具有持續發燒的登革感染癥狀或接觸史的患者的輔助性診斷。

6、登革IgM & IgG聯檢ELISA(Dengue Duo IgM & IgG Capture ELISA E-DEN01D)
用于定性檢測血清中登革病毒的IgM和IgG抗體。可以區分原發感染與繼發感染。

Dengue產品介紹

Panbio

研究過程/登革熱病 panbio登革熱
蚊子是登革熱病的傳播媒介
蚊子是登革熱病的傳播媒介
1648年，美洲的YUCATAN半島*證實登革熱病的流行。后此病被帶到歐洲及北美，在差不多兩個世紀內，登革熱病成為美、非、歐三大洲一些地方zui嚴重的瘟疫之一，造成大量人群死亡。
1901年，美國沃爾特里德（Walter Reed）首先證明登革熱病是由病毒引起的。一位古巴醫生卡洛斯·芬萊花了19年時間試圖證明：和瘧疾一樣，登革熱病也是由蚊子引起的。雖然他的所有實驗都失敗了。但沃爾特·里德和他的研究小組卻認同芬萊的理論。
登革熱病的傳播媒介是蚊，城市型登革熱病的傳播媒介是埃及伊蚊，西非也是埃及伊蚊，東非有可能是黃頭伊蚊、白點伊蚊和泰氏伊蚊等。人與人之間是通過蚊叮刺病人傳播的。叢林型登革熱病是獸類的地方病，也是家畜的流行病。若人偶然進入森林，被蚊叮刺后可以得病。
1927年通過猴和鼠的接種，獲得了登革熱病毒。此病毒屬于節肢動物傳播的病毒的黃病毒科，是RNA病毒。易感的動物限于哺乳動物。可用多種細胞培養，例如鼠胚、雞胚、豬腎、地鼠腎、綠猴腎和蚊細胞。具有嗜內臟性和嗜神經性。已分離出多株病毒。
20世紀30年代末，登革熱病毒減毒活疫苗17D株研制成功并被廣泛用于流行地區的預防接種，登革熱病流行強度明顯受到抑制，曾一度使登革熱病逐步消失，疫情于間歇和靜止狀態。
20世紀50年代末60年代初，人們降低了對登革熱病的警惕，忽視了對登革熱病的監測和預防接種，結果新的流行又不斷出現。
流行情況/登革熱病 panbio登革熱
人類記載的*次登革熱病流行發生在1648年的墨西哥的尤卡坦半島。此前在加勒比海地區已有該病存在。
17至19世紀，該病通過交通運輸、人員流動傳人北美和歐洲后，成為美洲、非洲及歐洲部分地區zui嚴重的傳染病之一，曾造成人群大量死亡及部分社會活動癱瘓。
1741年，英國27000名士兵攻打哥倫比亞，因20000人感染登革熱病而潰不成軍；1762年英國殖民軍侵略古巴，15000名士兵中8000人死于登革熱?。?br />1793年，美國費城登革熱病大流行，全市1/5人口死于登革熱病，導致社會*解體。其后疫情沿密西西比河深人到北美中心地帶，美國至少有50萬人罹患此?。?br />1800年，西班牙發生登革熱病，死亡至少6萬人；
1851年，巴西首都里約熱內盧因登革熱病至少死亡23000人；

Panbio

我司還提供其它進口或國產試劑盒：登革熱、瘧疾、乙腦、寨卡、黃熱病、基孔肯雅熱、克錐蟲病、違禁品濫用、肺炎球菌、軍團菌等試劑盒以及日本生研細菌分型診斷血清、德國SiFin診斷血清、丹麥SSI診斷血清等產品。

想了解更多的Panbio產品及服務請掃描下方二維碼：

【公司名稱】 廣州健侖生物科技有限公司
【市場部】    楊永漢

【】 
【騰訊  】 2042552662
【公司地址】 廣州清華科技園創新基地番禺石樓鎮創啟路63號二期2幢101-103室

references：

Research process / dengue fever panbio dengue fever
Mosquitoes are the medium of dengue fever
Mosquitoes are the medium of dengue fever
In 1648, the Americas YUCATAN Peninsula for the first time confirmed the prevalence of dengue fever. After the disease was brought to Europe and North America, in almost two centuries, dengue fever became one of the most serious plagues in the United States, Africa and Europe on three continents, causing a large number of people to die.
In 1901, the United States Walter Reed (Walter Reed) first proved that dengue fever is caused by the virus. A Cuban doctor, Carlos Finlé, spent 19 years trying to prove that, like malaria, dengue fever is caused by mosquitoes. Although all his experiments failed. But Walter Reed and his team agree with Finlay's theory.
The vector of dengue fever is mosquitoes. The vector of urban dengue fever is Aedes aegypti, and Aedes aegypti in East Africa, and Aedes albopictus, Aedes albopictus and Aedes albopictus. Between people through mosquito bites spread the patient. Jungle dengue fever is a place where the mammals are endemic and are also livestock epidemics. If people accidentally into the forest, mosquito bites can be sick after the disease
In 1927 through the monkey and rat vaccination, access to dengue virus. This virus belongs to the arthropod-transmitted virus of the Flaviviridae, which is an RNA virus. Susceptible animals are limited to mammals. A variety of cell cultures can be used, such as mouse embryos, chicken embryos, porcine kidney, hamster kidney, green monkey kidney and mosquito cells. With visceral and neuroticism. Multiple strains have been isolated.
In the late 1930s, dengue virus attenuated live vaccine 17D strain was successfully developed and widely used in epidemic areas of vaccination, dengue fever epidemic intensity was significantly inhibited, once the dengue fever gradually disappeared, the epidemic in the intermittent and quiescent state.
In the late 1950s and early 1960s, people were wary of dengue fever, neglected the surveillance and vaccination of dengue fever, and the new epidemic was emerging.
Epidemic situation / dengue fever panbio dengue fever
The first recorded dengue fever epidemic in humans occurred in the 1648 Mexican Yucatan Peninsula. The disease had previously existed in the Caribbean.
From the 17th to the 19th century, the disease became one of the most serious infectious diseases in the Americas, Africa and parts of Europe through transportation and personnel transmission to North America and Europe, which caused a large number of deaths and paralysis of some social activities.
In 1741, the United Kingdom 27,000 soldiers attacked Colombia, due to 20,000 people infected with dengue fever and failed; 1762 British colonial army invaded Cuba, 15,000 soldiers in 8000 people died of dengue fever;
In 1793, the United States Philadelphia dengue fever pandemic, the city's 1/5 population died of dengue fever, leading to the community compley disintegrated. Followed by the epidemic along the Mississippi River deep to the North American center, the United States at least 50 million people suffering from the disease;
In 1800, dengue fever occurred in Spain, killing at least 60,000 people;
In 1851, the Brazilian capital Rio de Janeiro died of dengue fever at least 23,000 people;